articleTop 10% cited

Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients

Clinical Endocrinology · 1998 · Vol. 48(3) · pp. 265–273

E Modigliani✉(Hôpital Avicenne)R. Cohen(Hôpital Avicenne)José‐Marie Campos(Hôpital Avicenne)B. Conte‐Devolx(Hôpital de la Timone)Béatrice Maes(Institut Jean Godinot)A Boneu(Institut Claudius Regaud)Martin Schlumberger(Institut Gustave Roussy)Jean‐Claude Bigorgne(Centre Hospitalier Universitaire d'Angers)Philippe Dumontier(Centre Hospitalier Universitaire d'Angers)Laurence LeclercB Corcuff(Centre Hospitalier Universitaire de Bordeaux)Isabelle Guilhem(Centre Hospitalier Universitaire de Rennes)

View via DOI Publisher page

Abstract

Survival of these medullary thyroid carcinoma patients appears better than expected even in non-cured patients. Considering the strong impact of stage, the necessity for pre-operative diagnosis of MTC is obvious.

Thyroid Cancer Diagnosis and Treatment Genetic factors in colorectal cancer Hedgehog Signaling Pathway StudiesMedicineCalcitoninStage (stratigraphy)Thyroid carcinomaInternal medicineMultivariate analysisProportional hazards modelMedullary carcinomaUnivariate analysisHazard ratio

MeSH terms

AdultAge FactorsAnalysis of VarianceCalcitoninFemaleHumansMaleMiddle AgedNeoplasm StagingPrognosisThyroid NeoplasmsProportional Hazards ModelsSurvival AnalysisDatabases, FactualCarcinoma, Medullary

Citations

567

FWCI

5.39

field-weighted impact

References

Percentile

97%

vs. same field & year

Citations per year

Cited by

Guidelines for the management of thyroid cancer